Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 13, 2017 07:00 ET | Source: Cempra, Inc.

Cempra Retains Morgan Stanley to Lead Review of Strategic Business Options

CHAPEL HILL, N.C., March 13, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
March 03, 2017 07:00 ET | Source: Cempra, Inc.

Cempra to Present at 29th Annual ROTH Conference

CHAPEL HILL, N.C., March 03, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
February 28, 2017 06:45 ET | Source: Cempra, Inc.

Cempra Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results

—Management to host webcast and conference call today at 8:45 a.m. ET— CHAPEL HILL, N.C., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company...
February 24, 2017 07:00 ET | Source: Cempra, Inc.

Cempra’s Fusidic Acid Achieves Primary Endpoint in Phase 3 Study of ABSSSI

—Fusidic acid met primary endpoint and secondary efficacy endpoints— —Fusidic acid well tolerated in the study— CHAPEL HILL, N.C., Feb. 24, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a...
February 14, 2017 16:15 ET | Source: Cempra, Inc.

Cempra to Report Fourth Quarter and Full Year 2016 Financial Results

CHAPEL HILL, N.C., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
February 08, 2017 09:41 ET | Source: Cempra, Inc.

CORRECTING and REPLACING -- Cempra to Present at Upcoming Investor Conferences

CHAPEL HILL, N.C., Feb. 08, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Cempra, Inc. (Nasdaq:CEMP), the Leerink Partners conference should be noted...
February 08, 2017 07:30 ET | Source: Cempra, Inc.

Cempra to Present at Upcoming Investor Conferences

CHAPEL HILL, N.C., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
January 04, 2017 07:00 ET | Source: Cempra, Inc.

Cempra to Present at J.P. Morgan Healthcare Conference

CHAPEL HILL, N.C., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
December 29, 2016 06:55 ET | Source: Cempra, Inc.

Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs

CHAPEL HILL, N.C., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
December 12, 2016 09:01 ET | Source: Cempra, Inc.

Cempra Appoints Dr. David Zaccardelli as Acting Chief Executive Officer, Promotes Chief Commercial Officer David Moore to President

—Leadership changes bolster manufacturing, regulatory and commercial expertise— —Cempra founder, president and CEO, Dr. Prabhavathi Fernandes, announces retirement from the company and...

Next Page keyboard_arrow_right